We propose to investigate the determinants of substrate specificity of cyclic AMP-dependent and cyclic GMP-dependent protein kinases. Synthetic peptides will be used in these studies as model substrates and inhibitors of the protein kinases. An undecapeptide that corresponds to the sequence of amino acids at the site of autophosphorylation in cyclic GMP-dependent protein kinase will be used to examine the kinetics and substrate specificity of this enzyme. The contribution of specificic amino acids to the ability of the peptide to be phosphorylated by either cyclic GMP-dependent or cyclic AMP-dependent protein kinase will be determined by replacement of individual residues and evaluation of the kinetic constants for these analogs of the peptide. The autophosphorylation site peptide will also be used to probe the interaction of the regulatory domain of the cyclic GMP-dependent protein kinase with its catalytic site. Additionally, synthetic peptides will be employed in the generation, purification, and characterization of site-specific antibodies to be used as probes of the sites of phosphorylation on protein substrates of the cyclic AMP-dependent protein kinase. L-type pyruvate kinase and peptides corresponding to the sequence of residues at the phosphorylation site in this protein will be used as immunogens to produce monoclonal antibodies. Antibodies directed toward determinants within either the dephospho- or phospho-forms of the phosphorylation site will be purified, and their specificities and affinities will be characterized. These site-specific antibodies will be used to investigate the regulation of pyruvate kinase activity and to immunologically characterize the structures of phosphorylation sites in other known substrates of the protein kinase. These experiments should provide new information about the molecular details that dictate the determinants of specificity of the cyclic nucleotide-dependent protein kinases. An increased understanding of the differences in the specificities between the two protein kinases may allow the development of selective inhibitors of each enzyme. The site-specific immunological reagents developed in these investigations should be useful biochemical and histochemical tools in the study of the physiological roles of the protein kinases and their substrates in hormone action.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM028144-06
Application #
3275428
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1980-07-01
Project End
1986-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Glass, D B; Trewhella, J; Mitchell, R D et al. (1995) Conformationally constrained analogs of protein kinase inhibitor (6-22)amide: effect of turn structures in the center of the peptide on inhibition of cAMP-dependent protein kinase. Protein Sci 4:405-15
Glass, D B; Feller, M J; Levin, L R et al. (1992) Structural basis for the low affinities of yeast cAMP-dependent and mammalian cGMP-dependent protein kinases for protein kinase inhibitor peptides. Biochemistry 31:1728-34
Glass, D B; Robertson, D G; Xu, T S et al. (1991) Chemical synthesis, initial conformational studies, and activity of rat steroidogenesis activator peptide and a truncated analog. Endocr Res 17:307-26
Glass, D B; Cheng, H C; Mende-Mueller, L et al. (1989) Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem 264:8802-10
Reed, J; De Ropp, J S; Trewhella, J et al. (1989) Conformational analysis of PKI(5-22)amide, the active inhibitory fragment of the inhibitor protein of the cyclic AMP-dependent protein kinase. Biochem J 264:371-80
Katz, B M; Lundquist, L J; Walsh, D A et al. (1989) Synthesis, characterization and inhibitory activities of (4-N3[3,5-3H]Phe10)PKI(6-22)amide and its precursors: photoaffinity labeling peptides for the active site of cyclic AMP-dependent protein kinase. Int J Pept Protein Res 33:439-45
Glass, D B; Lundquist, L J; Katz, B M et al. (1989) Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. J Biol Chem 264:14579-84
Lamb, N J; Fernandez, A; Conti, M A et al. (1988) Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J Cell Biol 106:1955-71
Bhatnagar, D; Glass, D B; Roskoski Jr, R et al. (1988) Synthetic peptide analogues differentially alter the binding affinities of cyclic nucleotide dependent protein kinases for nucleotide substrates. Biochemistry 27:1988-94
Aswad, D W; Johnson, B A; Glass, D B (1987) Modification of synthetic peptides related to lactate dehydrogenase (231-242) by protein carboxyl methyltransferase and tyrosine protein kinase: effects of introducing an isopeptide bond between aspartic acid-235 and serine-236. Biochemistry 26:675-81

Showing the most recent 10 out of 18 publications